Healthcare >> CEO Interviews >> December 14, 1998
SAM ELETR, Ph.D., is the founding Chairman of the Board and Chief
Executive Officer of Lynx Therapeutics, Inc. Lynx was formed in 1992 as
a 'spin-off' of Applied Biosystems, Inc. ('ABI'), a manufacturer of
instruments and consumables for life science research and related
applications. Dr. Eletr co-founded ABI, now a wholly-owned subsidiary of
Perkin-Elmer Corporation and served as CEO and Chairman of the Board,
and in various other executive positions at ABI from its inception until
March 1987. Dr. Eletr acted as a consultant to ABI from September 1990
until July 1992, at which time he undertook to assume the leadership of
Lynx. Dr. Eletr received a Master's degree in Physics and a Ph.D. in
Physical Chemistry from the University of California at Berkeley.
Following post-doctoral research at the CNRS in France and at the
University of California School of Medicine in San Francisco, he joined
the staff of the Hewlett-Packard Corporate Research Laboratories where
he headed a group responsible for the Development of Analytical and
Medical Instruments before leaving HP to undertake the formation of ABI. Profile
of Lynx just to set the scene for our readers?
Dr. Eletr: Lynx began operations in late 1992. It currently numbers
